Cargando…

Medical Summary Template for the Transfer of Patients with Inflammatory Bowel Disease from Pediatric to Adult Care

BACKGROUND: The transfer of information is a key aspect of the transition of adolescent patients with inflammatory bowel disease (IBD) from pediatric to adult care. This is typically accomplished through the use of a consultation letter with a medical summary of the patient being transferred. To imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benchimol, Eric I, Afif, Waqqas, Plamondon, Sophie, Newhook, Dennis, Nicholls, Stuart G, Lévesque, Dominique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806045/ https://www.ncbi.nlm.nih.gov/pubmed/35118221 http://dx.doi.org/10.1093/jcag/gwab009

Ejemplares similares

Update on TDM (Therapeutic Drug Monitoring) with Ustekinumab, Vedolizumab and Tofacitinib in Inflammatory Bowel Disease
por: Restellini, Sophie, et al.
Publicado: (2021)

Therapeutic drug monitoring in inflammatory bowel disease: The dawn of reactive monitoring
por: Albader, Farah, et al.
Publicado: (2021)

Patient Perspectives and Expectations in Inflammatory Bowel Disease: A Systematic Review
por: Al Khoury, Alex, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases
por: Kablawi, Dana, et al.
Publicado: (2023)

The Challenges of Living with Inflammatory Bowel Disease: Summary of a Summit on Patient and Healthcare Provider Perspectives
por: Bray, Judith, et al.
Publicado: (2016)

Maladaptive coping, low self-efficacy and disease activity are associated with poorer patient-reported outcomes in inflammatory bowel disease
por: Chao, Che-Yung, et al.
Publicado: (2019)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Executive Summary
por: Windsor, Joseph W, et al.
Publicado: (2023)

Concordance between tuberculin skin test and interferon-gamma release assay for latent tuberculosis screening in inflammatory bowel disease
por: Alrajhi, Saad, et al.
Publicado: (2020)

Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease
por: Wetwittayakhlang, Panu, et al.
Publicado: (2021)

Safety of Biological Therapies in Elderly Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
por: Hahn, Gustavo Drügg, et al.
Publicado: (2022)

Canadian Consensus Statements on the Transition of Adolescents and Young Adults with Inflammatory Bowel Disease from Pediatric to Adult Care: A Collaborative Initiative Between the Canadian IBD Transition Network and Crohn’s and Colitis Canada
por: Fu, Nancy, et al.
Publicado: (2022)

Increased Prevalence of Myocardial Infarction and Stable Stroke Proportions in Patients with Inflammatory Bowel Diseases in Quebec in 1996–2015
por: Golovics, Petra Anna, et al.
Publicado: (2022)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary
por: Ellen Kuenzig, M, et al.
Publicado: (2021)

Comparing Health Administrative and Clinical Registry Data: Trends in Incidence and Prevalence of Pediatric Inflammatory Bowel Disease in British Columbia
por: Chan, Justin M, et al.
Publicado: (2021)

Cost of Refractory Crohn’s Disease Before and After Ustekinumab Utilization
por: Rahme, Elham, et al.
Publicado: (2019)

Benefits of implementing a rapid access clinic in a high-volume inflammatory bowel disease center: Access, resource utilization and outcomes
por: Nene, Sofia, et al.
Publicado: (2020)

Effectiveness, safety, and drug sustainability of biologics in elderly patients with inflammatory bowel disease: A retrospective study
por: Hahn, Gustavo Drügg, et al.
Publicado: (2022)

Transition care in inflammatory bowel disease: A needs assessment survey of Quebec gastroenterologists and allied nurses
por: Strohl, Matthew, et al.
Publicado: (2017)

Real world evidence of the association between medication and life expectancy in elderly inflammatory bowel disease: a population-based cohort study
por: Kuenzig, M. Ellen, et al.
Publicado: (2022)

Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease
por: Moayyedi, Paul, et al.
Publicado: (2020)

Co-occurrence of Asthma and the Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis
por: Kuenzig, M. Ellen, et al.
Publicado: (2018)

Ultrasonography in pediatric inflammatory bowel diseases
por: Massimetti, Mauro, et al.
Publicado: (2014)

Adalimumab in Pediatric Inflammatory Bowel Disease
por: Choi, So Yoon, et al.
Publicado: (2022)

The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology
por: Kaplan, Gilaad G, et al.
Publicado: (2019)

Methods for Measuring the Time of Transfer from Pediatric to Adult Care for Chronic Conditions Using Administrative Data: A Scoping Review
por: Shulman, Rayzel, et al.
Publicado: (2020)

Improving the transitioning of pediatric patients with type 1 diabetes into adult care by initiating a dedicated single session transfer clinic
por: Williams, Sarah, et al.
Publicado: (2020)

Hospitalization With Clostridioides difficile in Pediatric Inflammatory Bowel Disease: a Population-Based Study
por: Kuenzig, M. Ellen, et al.
Publicado: (2022)

The pediatric template of brain perfusion
por: Avants, Brian B, et al.
Publicado: (2015)

Dysbiosis in the Pathogenesis of Pediatric Inflammatory Bowel Diseases
por: Comito, Donatella, et al.
Publicado: (2012)

Pancreatic Involvement in Pediatric Inflammatory Bowel Disease
por: Martín-de-Carpi, Javier, et al.
Publicado: (2017)

Nutritional concerns in pediatric inflammatory bowel disease
por: Kim, Yong Joo
Publicado: (2016)

Dermatological Manifestations in Pediatric Inflammatory Bowel Disease
por: Diaconescu, Smaranda, et al.
Publicado: (2020)

Diet and Nutrition in Pediatric Inflammatory Bowel Diseases
por: Cucinotta, Ugo, et al.
Publicado: (2021)

Reporting transparency: making the ethical mandate explicit
por: Nicholls, Stuart G., et al.
Publicado: (2016)

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors
por: Nguyen, Geoffrey C, et al.
Publicado: (2019)

The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs)
por: Vadasz, Zahava, et al.
Publicado: (2015)

Joint Canadian Association of Gastroenterology and Crohn’s Colitis Canada Position Statement on Biosimilars for the Treatment of Inflammatory Bowel Disease
por: Moayyedi, Paul, et al.
Publicado: (2019)

The Impact of Inflammatory Bowel Disease in Canada 2018: Quality of Life
por: Jones, Jennifer L, et al.
Publicado: (2019)

Uptake of third doses of SARS-CoV-2 vaccines among people with inflammatory bowel disease in Ontario, Canada
por: Kuenzig, M Ellen, et al.
Publicado: (2022)

The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD
por: Bernstein, Charles N, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0od7pbnes5ugbtni6lombatr4d